Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer ; volume:15 ; number:1 ; day:9 ; month:6 ; year:2020 ; pages:1-9 ; date:12.2020
Radiation oncology ; 15, Heft 1 (9.6.2020), 1-9, 12.2020
- Urheber
-
Taugner, Julian
Eze, Chukwuka
Käsmann, Lukas
Roengvoraphoj, Olarn
Gennen, Kathrin
Karin, Monika
Petrukhnov, Oleg
Tufman, Amanda
Belka, Claus
Manapov, Farkhad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-020-01590-8
- URN
-
urn:nbn:de:101:1-2020080822312352174437
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Taugner, Julian
- Eze, Chukwuka
- Käsmann, Lukas
- Roengvoraphoj, Olarn
- Gennen, Kathrin
- Karin, Monika
- Petrukhnov, Oleg
- Tufman, Amanda
- Belka, Claus
- Manapov, Farkhad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons
Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
Magnetic resonance-guided radiation therapy: the beginning of a new era
Prostate intra-fraction motion recorded by transperineal ultrasound
The role of PDGF in radiation oncology
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy
Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons
Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
Magnetic resonance-guided radiation therapy: the beginning of a new era
Prostate intra-fraction motion recorded by transperineal ultrasound
The role of PDGF in radiation oncology
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis
Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy
Charakterisierung und Identitätsklärung eines mit dem Retinoblastomgen kreuzhybridisierenden DNA-Klons
Molekularbiologie des strahleninduzierten Zelltods : Bedeutung für die Strahlenwirkung und die Entwicklung neuer Therapiekonzepte
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
Magnetic resonance-guided radiation therapy: the beginning of a new era
Prostate intra-fraction motion recorded by transperineal ultrasound
The role of PDGF in radiation oncology
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis